Implantation of an ultrafiltration device in the ileum and spiral colon of steers to continuously collect intestinal fluid.

Collection of fluid from the lumen of the gastrointestinal tract is commonly necessary for research projects, but presents challenges including intestinal motility and potential for leakage of intestinal contents. In this study, ultrafiltration collection devices were surgically implanted in the ileum and spiral colon of 12 steers for repeated collection of intestinal fluid over 48 hours. There were no significant complications associated with surgery or during the post-operative period, nor were there any significant pathologic changes found at necropsy 3 or 4 days post-surgery. Over 48 hours, we obtained 88% of the desired 212 samples. Only two devices failed to routinely collect samples. Use of ultrafiltration probes is a novel, consistent and humane method to repeatedly sample the gastrointestinal contents.

Evaluation of 30- and 25-diopter intraocular lens implants in equine eyes after surgical extraction of the lens.

OBJECTIVE: To determine appropriate intraocular lens (IOL) implant strength to approximate emmetropia in horses. SAMPLE POPULATION: 16 enucleated globes and 4 adult horses. PROCEDURES: Lens diameter of 10 enucleated globes was measured. Results were used to determine the appropriate-sized IOL implant for insertion in 6 enucleated globes and 4 eyes of adult horses. Streak retinoscopy and ocular ultrasonography were performed before and after insertion of 30-diopter (D) IOL implants (enucleated globes) and insertion of 25-D IOL implants (adult horses). RESULTS: In enucleated globes, mean +/- SD lens diameter was 20.14 +/- 0.75 mm. Preoperative and postoperative refractive state of enucleated globes with 30-D IOL implants was -0.46 +/- 1.03 D and -2.47 +/- 1.03 D, respectively; preoperative and postoperative difference in refraction was 2.96 +/- 0.84 D. Preoperative anterior chamber (AC) depth, crystalline lens thickness (CLT), and axial globe length (AxL) were 712 +/- 0.82 mm, 11.32 +/- 0.81 mm, and 40.52 +/- 1.26 mm, respectively; postoperative AC depth was 10.76 +/- 1.16 mm. Mean ratio of preoperative to postoperative AC depth was 0.68. In eyes receiving 25-D IOL implants, preoperative and postoperative mean refractive error was 0.08 +/- 0.68 D and -3.94 +/- 1.88 D, respectively. Preoperative AC depth, CLT, and AxL were 6.36 +/- 0.22 mm, 10.92 +/- 1.92 mm, and 38.64 +/- 2.59 mm, respectively. Postoperative AC depth was 8.99 +/- 1.68 mm. Mean ratio of preoperative to postoperative AC depth was 0.73. CONCLUSIONS AND CLINICAL RELEVANCE: Insertion of 30-D (enucleated globes) and 25-D IOL implants (adult horses) resulted in overcorrection of refractive error.

Anti-inflammatory effects of intravenously administered lidocaine hydrochloride on ischemia-injured jejunum in horses.

OBJECTIVE: To investigate effects of lidocaine hydrochloride administered IV on mucosal inflammation in ischemia-injured jejunum of horses treated with flunixin meglumine. ANIMALS: 24 horses. PROCEDURES: Horses received saline (0.9% NaCl) solution (SS; 1 mL/50 kg, IV [1 dose]), flunixin meglumine (1 mg/kg, IV, q 12 h), lidocaine (bolus [1.3 mg/kg] and constant rate infusion [0.05 mg/kg/min], IV, during and after recovery from surgery), or both flunixin and lidocaine (n = 6/group). During surgery, blood flow was occluded for 2 hours in 2 sections of jejunum in each horse. Uninjured and ischemia-injured jejunal specimens were collected after the ischemic period and after euthanasia 18 hours later for histologic assessment and determination of cyclooxygenase (COX) expression (via western blot procedures). Plasma samples collected prior to (baseline) and 8 hours after the ischemic period were analyzed for prostanoid concentrations. RESULTS: Immediately after the ischemic period, COX-2 expression in horses treated with lidocaine alone was significantly less than expression in horses treated with SS or flunixin alone. Eighteen hours after the ischemic period, mucosal neutrophil counts in horses treated with flunixin alone were significantly higher than counts in other treatment groups. Compared with baseline plasma concentrations, postischemia prostaglandin E(2) metabolite and thromboxane B(2) concentrations increased in horses treated with SS and in horses treated with SS or lidocaine alone, respectively. CONCLUSIONS AND CLINICAL RELEVANCE: In horses with ischemia-injured jejunum, lidocaine administered IV reduced plasma prostaglandin E(2) metabolite concentration and mucosal COX-2 expression. Coadministration of lidocaine with flunixin ameliorated the flunixin-induced increase in mucosal neutrophil counts.

Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.

OBJECTIVE: To determine whether treatment of horses with firocoxib affects recovery of ischemic-injured jejunum, while providing effective analgesia. ANIMALS: 18 horses. PROCEDURES: Horses (n = 6 horses/group) received saline (0.9% NaCl) solution (1 mL/50 kg, IV), flunixin meglumine (1.1 mg/kg, IV, q 12 h), or firocoxib (0.09 mg/kg, IV, q 24 h) before 2 hours of jejunal ischemia. Horses were monitored via pain scores and received butorphanol for analgesia. After 18 hours, ischemic-injured and control mucosa were placed in Ussing chambers for measurement of transepithelial resistance and permeability to lipopolysaccharide. Histomorphometry was used to determine denuded villus surface area. Western blots for cyclooxygenase (COX)-1 and COX-2 were performed. Plasma thromboxane B(2) and prostaglandin E(2) metabolite (PGEM) concentrations were determined. RESULTS: Pain scores did not significantly increase after surgery in horses receiving flunixin meglumine or firocoxib. Transepithelial resistance of ischemic-injured jejunum from horses treated with flunixin meglumine was significantly lower than in saline- or firocoxib-treated horses. Lipopolysaccharide permeability across ischemic-injured mucosa was significantly increased in horses treated with flunixin meglumine. Treatment did not affect epithelial restitution. Cyclooxygenase-1 was constitutively expressed and COX-2 was upregulated after 2 hours of ischemia. Thromboxane B(2) concentration decreased with flunixin meglumine treatment but increased with firocoxib or saline treatment. Flunixin meglumine and firocoxib prevented an increase in PGEM concentration after surgery. CONCLUSIONS AND CLINICAL RELEVANCE: Flunixin meglumine retarded mucosal recovery in ischemic-injured jejunum, whereas firocoxib did not. Flunixin meglumine and firocoxib were effective visceral analgesics. Firocoxib may be advantageous in horses recovering from ischemic intestinal injury.

A novel instrumented retractor to monitor tissue-disruptive forces during lateral thoracotomy.

OBJECTIVE: Acute and chronic pain after thoracotomy, post-thoracotomy pain syndrome, is well documented. The mechanical retractors used for the thoracotomy exert significant forces on the skeletal cage. Our hypothesis was that instrumented retractors could be developed to enable real-time monitoring and control of retraction forces. This would provide equivalent exposure with significantly reduced forces and tissue damage and thus less post-thoracotomy pain. METHODS: A novel instrumented retractor was designed and fabricated to enable real-time force monitoring during surgical retraction. Eight mature sheep underwent bilateral thoracotomy. One lateral thoracotomy was retracted at a standard clinical pace of 5.93 +/- 0.80 minutes to 7.5 cm without real-time monitoring of retraction forces. The other lateral thoracotomy was retracted to the same exposure with real-time visual force feedback and a consequently more deliberate pace of 9.87 +/- 1.89 minutes (P = .006). Retraction forces, blood pressure, and heart rate were monitored throughout the procedure. RESULTS: Full lateral retraction resulted in an average force of 102.88 +/- 50.36 N at the standard clinical pace, versus 77.88 +/- 38.85 N with force feedback (a 24.3% reduction, P = .006). Standard retraction produced peak forces of 450.01 +/- 129.58 N, whereas force feedback yielded peak forces of 323.99 +/- 127.79 N (a 28.0% reduction, P = .009). Systolic blood pressure was significantly higher during standard clinical retraction (P = .0097), and rib fracture occurrences were reduced from 5 to 1 with force feedback (P = .04). CONCLUSIONS: Use of the novel instrumented retractor resulted in significantly lower average and peak retraction forces during lateral thoracotomy. Moreover, these reduced retraction forces were correlated with reductions in animal stress and tissue damage, as documented by lower systolic blood pressures and fewer rib fractures.

Tissue-disruptive forces during median sternotomy.

BACKGROUND: Acute and chronic pain after median sternotomy is common and often underestimated. The mechanical retractors used for median sternotomy exert significant forces on the skeletal cage. We hypothesized that instrumented retractors could be developed to enable real-time monitoring and control of retraction forces, functions that may provide equivalent exposure with significantly reduced forces and tissue damage, and thus, less postoperative pain. METHODS: We developed a novel instrumented retractor designed to enable real-time force monitoring during surgical retraction and then tested it by performing median sternotomies on 16 mature sheep. For 8 of these median sternotomies, retraction was performed to 7.5 cm at a standard "clinical pace" of 7.25 +/- 0.97 minutes without real-time monitoring of retraction forces. For the other 8 median sternotomies, we performed retraction to the same exposure using real-time visual force feedback and, consequently, a more deliberate pace of 12.05 +/- 1.73 minutes (P <.001). Retraction forces, blood pressure, and heart rate were monitored throughout the procedure. RESULTS: Full retraction resulted in an average force of 102.99 +/- 40.68 N at the standard clinical pace, compared to 64.68 +/- 17.60 N with force feedback (a 37.2% reduction, P = .021). Standard retraction produced peak forces of 368.79 +/- 133.61 N, whereas force feedback yielded peak forces of 254.84 +/- 75.77 N (a 30.9% reduction, P = .1152). Heart rate was significantly higher during standard clinical retraction (P = .025). CONCLUSIONS: Use of the novel instrumented retractor resulted in lower average and peak retraction forces during median sternotomy. Moreover, these reduced retraction forces correlated to a reduction in animal stress, as documented by heart rate.